Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice

Por Hodes, Georgia E., Hill-Smith, Tiffany E., Lucki, Irwin
Publicado no Neurosci Lett (2010)

Reversal of dopamine system dysfunction in response to high fat diet

Por Carlin, JesseLea, Hill-Smith, Tiffany E., Lucki, Irwin, Reyes, Teresa M.
Publicado em 2013

Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History

Por Snyder, Kevin P, Hill-Smith, Tiffany E, Lucki, Irwin, Valentino, Rita J
Publicado no Neuropsychopharmacology (2015)

Effects of Buprenorphine on Behavioral Tests for Antidepressant and Anxiolytic Drugs in Mice

Por Falcon, Edgardo, Maier, Kaitlyn, Robinson, Shivon A., Hill-Smith, Tiffany E., Lucki, Irwin
Publicado no Psychopharmacology (Berl) (2014)

Sex-Specific Effects of Chronic Fluoxetine Treatment on Neuroplasticity and Pharmacokinetics in Mice

Por Hodes, Georgia E., Hill-Smith, Tiffany E., Suckow, Raymond F., Cooper, Thomas B., Lucki, Irwin
Publicado em 2010

Strain Differences in the Effects of Chronic Corticosterone Exposure in the Hippocampus

Por Hodes, Georgia E., Brookshire, Bethany, Hill-Smith, Tiffany E., Teegarden, Sarah L., Berton, Olivier, Lucki, Irwin
Publicado em 2012

Early Life Protein Restriction Alters Dopamine Circuitry

Por Vucetic, Zivjena, Totoki, Kathy, Schoch, Hannah, Whitaker, Keith W., Hill-Smith, Tiffany, Lucki, Irwin, Reyes, Teresa M.
Publicado em 2010

Brain Monoamines and Antidepressant-like Responses in MRL/MpJ Versus C57BL/6J Mice

Por Balu, Darrick T., Turner, Jill R., Brookshire, Bethany R., Hill-Smith, Tiffany E., Blendy, Julie A., Lucki, Irwin
Publicado em 2012

Akt1 Deficiency in Schizophrenia and Impairment of Hippocampal Plasticity and Function

Por Balu, Darrick T., Carlson, Gregory C., Talbot, Konrad, Kazi, Hala, Hill-Smith, Tiffany E., Easton, Rachel M., Birnbaum, Morris J., Lucki, Irwin
Publicado em 2010

D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI

Por Santini, Martin A., Balu, Darrick T., Puhl, Matthew D., Hill-Smith, Tiffany E., Berg, Alexandra R., Lucki, Irwin, Mikkelsen, Jens D., Coyle, Joseph T.
Publicado em 2013